Gene regulation by morpholines and piperidines in the cardiac embryonic stem cell test

R H Mennen1, N Hallmark2, M Pallardy3

  • 1Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

Insights

The cardiac embryonic stem cell test (ESTc) can identify chemical toxicity by measuring gene biomarkers. Specifying the biological domain allowed for in vitro discrimination between similar chemicals, improving the test's utility.

Area of Science:

  • Developmental toxicology
  • In vitro toxicology
  • Stem cell biology

Background:

  • The cardiac embryonic stem cell test (ESTc) is an in vitro screen for embryotoxicity.
  • Improving ESTc applicability may involve specifying biological domains and measuring gene biomarkers.
  • Structurally similar chemicals can cause developmental toxicity, such as cleft palate in rats, linked to retinoic acid, neural crest migration, or cholesterol biosynthesis.

Purpose of the Study:

  • To explore specifying the biological domain of the ESTc for discriminating between morpholine and piperidine classes of chemicals.
  • To investigate the effects of these compounds on cardiomyocyte and neural differentiation markers.
  • To assess the utility of gene transcript biomarkers in understanding chemical-induced embryotoxicity.

Main Methods:

  • Utilized the ESTc with cardiomyocyte differentiation.
  • Exposed differentiating cells to morpholines (tridemorph, fenpropimorph) and piperidines (fenpropidin, spiroxamine) at varying concentrations.
  • Measured gene transcript expression of biomarkers related to cholesterol biosynthesis (Msmo1), retinoic acid metabolism (Cyp26a1), cardiomyocyte differentiation (Nkx2-5, Myh6), and neural differentiation (Tubb3) at differentiation day 4 (DD4) and DD10.

Main Results:

  • All tested compounds stimulated the cholesterol biosynthesis marker Msmo1 after 24 hours.
  • Tridemorph inhibited Cyp26a1, an enzyme metabolizing retinoic acid.
  • Longer exposure (DD10) enhanced differentiation markers for cardiomyocytes and neural cells, enabling in vitro discrimination between the chemical classes.

Conclusions:

  • Specifying the biological domain of the ESTc by measuring dedicated gene transcript biomarkers enhances its applicability.
  • This approach provides mechanistic insight and allows for in vitro discrimination between structurally similar, toxic chemicals.
  • The study demonstrates the practical utility of refining the ESTc for targeted toxicological assessments.

Related Concept Videos